Get The Alerts + Report

Tyra Biosciences, Inc. [TYRA]

Reporting date: 02/12/2026

⚠️ Neutral Insider Sale Detected

📝 What Happened

  • Insider: Bensen Daniel
  • Role: Chief Discovery Officer (Officer)
  • Company: Tyra Biosciences, Inc. (TYRA)
  • Transaction Date(s): 2026-02-12
  • Table I (Non-Derivative Securities)
    • Sale : 8,000 shares
    • Average Sale Price: $32.87 (weighted average of reported $31.5018 and $33.3666)
    • Total Value: 8,000 * $32.87 = ~ $262,966.11
    • Post-Transaction Direct Holdings: 146,981 shares
    • Indirect Holdings: None reported
    • 10b5-1 Plan Used? Yes (footnote indicates Rule 10b5-1 plan)

    📄 Summary

    Bensen Daniel, Chief Discovery Officer at Tyra Biosciences, Inc. (TYRA), sold 8,000 shares on February 12, 2026, at an average price of $32.87, realizing proceeds of about ~$262,966.11. After the transaction, he now holds 146,981 direct shares; no indirect holdings. For retail traders, this is a neutral-to-slightly bearish event: Scheduled plan sales, modest percentage of holdings sold.

    🔑 Interpretation

    • Type: Comp-related (executed pursuant to a Rule 10b5-1 trading plan)
    • Disposition: Sold under a pre-established plan (transactions executed as scheduled)
    • Size Context: 8,000 shares represents ~5.4% of post-transaction direct holdings (146,981) — modest size and consistent with routine profit-taking rather than a large divestiture
    • ATH Metric: The reported sale prices (~$31.02–$33.85 range; weighted ~$32.87) do not appear to be at extreme all-time highs or lows based on recent price history; the trades look executed under a plan rather than opportunistically timed to ATH/ATL moves.
    • Outlier Check: Not unusually large for an officer sale of this magnitude relative to holdings; no single large, extraordinary disposition reported here.

    📊 Bullish or Bearish?

    Neutral

    Neutral. The filing shows net sales of 8,000 shares executed under a Rule 10b5-1 plan (code S), indicating pre-planned disposals rather than discretionary insider selling; the size is modest relative to total holdings and the reporting is complete for these transactions. Cluster activity cannot be determined from this filing alone.

    ✅ Bottom Line (Retail Takeaway)

    This transaction looks like routine profit-taking under a 10b5-1 plan rather than a directional bearish signal. For retail traders, it’s likely noise — not a tradeable event on its own unless corroborated by large sales from the company’s CEO, CFO, or multiple insiders.